Arkolith/Insider Trading/SYRE/Form 4

Burrows Scott L

Chief Financial OfficerSpyre Therapeutics, Inc. (SYRE) · full profile →Form 4 · filed Aug 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$717K
Net Open-Market Flow
-$717K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)8K$14.50$109K105K
Aug 3, 2026Sell(S)5K$95.21$486K100K
Aug 3, 2026Sell(S)2K$96.30$221K98K
Aug 3, 2026Sell(S)100$97.10$10K98K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)8K—$0345K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001636282-26-000100) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Spyre Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp